➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim
Medtronic

Last Updated: October 27, 2020

DrugPatentWatch Database Preview

BETAMETHASONE DIPROPIONATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Betamethasone Dipropionate, and when can generic versions of Betamethasone Dipropionate launch?

Betamethasone Dipropionate is a drug marketed by Anda Repository, Fougera Pharms, Glenmark Generics, Perrigo Israel, Taro, Actavis Mid Atlantic, Cosette, Perrigo New York, Pharmaderm, Teva, Zydus Pharms, Hi Tech, Teligent Pharma Inc, Alpharma Us Pharms, Fougera Pharms Inc, Lupin Ltd, Cadila, and Taro Pharms. and is included in forty-four NDAs.

The generic ingredient in BETAMETHASONE DIPROPIONATE is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.

US ANDA Litigation and Generic Entry Outlook for Betamethasone Dipropionate

A generic version of BETAMETHASONE DIPROPIONATE was approved as betamethasone dipropionate by FOUGERA PHARMS on June 26th, 1984.

  Start Trial

Drug patent expirations by year for BETAMETHASONE DIPROPIONATE
Drug Prices for BETAMETHASONE DIPROPIONATE

See drug prices for BETAMETHASONE DIPROPIONATE

Drug Sales Revenue Trends for BETAMETHASONE DIPROPIONATE

See drug sales revenues for BETAMETHASONE DIPROPIONATE

Recent Clinical Trials for BETAMETHASONE DIPROPIONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Alabama at BirminghamPhase 4
Eli Lilly and CompanyPhase 4
Cairo UniversityN/A

See all BETAMETHASONE DIPROPIONATE clinical trials

Pharmacology for BETAMETHASONE DIPROPIONATE
Paragraph IV (Patent) Challenges for BETAMETHASONE DIPROPIONATE
Tradename Dosage Ingredient NDA Submissiondate
SERNIVO SPRAY;TOPICAL betamethasone dipropionate 208079 2018-02-15

US Patents and Regulatory Information for BETAMETHASONE DIPROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmaderm BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT;TOPICAL 019140-001 Sep 4, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Actavis Mid Atlantic BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT, AUGMENTED;TOPICAL 074304-001 Aug 31, 1995 AB RX No No   Start Trial   Start Trial   Start Trial
Perrigo New York BETAMETHASONE DIPROPIONATE betamethasone dipropionate LOTION;TOPICAL 072538-001 Jan 31, 1990 AB RX No No   Start Trial   Start Trial   Start Trial
Fougera Pharms BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT, AUGMENTED;TOPICAL 075373-001 Jun 22, 1999 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
AstraZeneca
Merck
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.